Top Treatment Options for Liver Cancer

Looking for the best treatment options for liver cancer? Dealing with a diagnosis of liver cancer can be overwhelming, but understanding the available treatments can empower you or your loved ones in making informed decisions. From surgical procedures like liver resection and liver transplantation to localized therapies such as radiofrequency ablation and transarterial chemoembolization (TACE), there are various approaches depending on the stage and type of liver cancer. Additionally, advances in targeted therapies and immunotherapy are expanding treatment possibilities, offering new hope in managing this complex disease. Join us as we explore the top treatment options for liver cancer, including how these options are transforming outcomes and providing personalized care across leading medical institutions worldwide.

1. Surgery

Surgery is often considered the primary treatment for liver cancer, especially when the tumour is localized within the liver and the patient is in good overall health. The surgical approach aims to remove cancerous tissue while preserving as much of the healthy liver as possible.

Types of Surgical Procedures:

a. Hepatectomy:

• Partial Hepatectomy: Involves removing a portion of the liver affected by cancer. The extent of resection depends on the size and location of the tumour, as well as the liver's functional capacity to regenerate.
• Total Hepatectomy: Rarely performed, this procedure involves removing the entire liver affected by cancer and is typically followed by a liver transplant.

b. Liver Transplant:

• Suitable for patients with small tumours or early-stage cancer who are not candidates for partial hepatectomy due to the size or location of the tumour.
• Involves replacing the diseased liver with a healthy liver from a compatible donor, offering a potential cure as the new liver is free from cancerous cells.

Procedure Details:

• Pre-operative Evaluation: Comprehensive assessment including imaging studies (CT scan, MRI) and liver function tests to determine the extent of cancer and the suitability for surgery.
• Surgical Approach: Conducted under general anaesthesia, the surgeon accesses the liver through an abdominal incision (open surgery) or minimally invasive techniques (laparoscopic or robotic-assisted surgery).
• Recovery: Post-operative care involves monitoring liver function, managing pain, and preventing complications such as infection or bleeding.
• Long-term Outlook: Successful surgery can lead to the complete removal of cancerous tissue, allowing for recovery and potential long-term survival. Follow-up care involves regular monitoring to detect any signs of recurrence.

Suitability and Risks: The patient's overall health, the extent of liver damage, and tumour characteristics (size, location) influence the feasibility and success of surgery. Potential risks include bleeding, infection, liver failure, and complications related to anaesthesia. The risk of complications is higher in patients with underlying liver disease or extensive tumour involvement.

Alternative Options: Surgery may not be suitable for all patients, especially those with advanced-stage cancer or significant underlying liver dysfunction. In such cases, alternative treatments like ablation therapy, radiation therapy, targeted therapy, or chemotherapy may be considered.

Surgery remains a cornerstone in the treatment of localized liver cancer, offering a potentially curative approach for eligible patients. The decision to undergo surgery should be made in consultation with a multidisciplinary team of specialists, including hepatobiliary surgeons, oncologists, and transplant specialists, to ensure personalized care and optimal treatment outcomes.

4. Targeted Therapy

Targeted therapy for liver cancer focuses on specific molecular targets involved in cancer cell growth and survival. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapies aim to selectively target cancer cells while minimizing damage to normal tissues.

Types of Targeted Therapies:

1. Tyrosine Kinase Inhibitors (TKIs):

• Mechanism: TKIs work by blocking specific enzymes (tyrosine kinases) that are involved in signalling pathways essential for cancer cell growth and proliferation.
• Effectiveness: By inhibiting these pathways, TKIs can slow down tumour growth and progression in patients with advanced liver cancer.
• Examples: Sorafenib and lenvatinib are examples of TKIs approved for the treatment of advanced hepatocellular carcinoma (HCC). They target multiple tyrosine kinases involved in angiogenesis (blood vessel formation) and tumour cell proliferation.

• Mechanism: Monoclonal antibodies are designed to target specific proteins present on the surface of cancer cells or within the tumour microenvironment.
• Enhanced Immune Response: By binding to these targets, monoclonal antibodies can help the immune system recognize and attack liver cancer cells more effectively.
• Examples: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), a protein involved in angiogenesis. It is used in combination with other therapies for the treatment of advanced HCC to inhibit tumour blood vessel formation and growth.

Clinical Application:

• Patient Selection: Targeted therapies are typically used in patients with advanced liver cancer or those who have not responded to other treatments.
• Combination Therapies: Often used in combination with other treatment modalities such as surgery, chemotherapy, or radiation therapy to enhance treatment efficacy.
• Side Effects: Side effects of targeted therapies may include hypertension, fatigue, diarrhoea, and skin reactions, which are managed through supportive care and dose adjustments.
• Monitoring: Regular monitoring of treatment response through imaging studies and laboratory tests is crucial to evaluate tumour response and adjust therapy as needed.

Targeted therapy represents a promising approach in the treatment landscape for liver cancer, offering selective and effective treatments that can improve outcomes for patients with advanced disease. As research continues to uncover new molecular targets and develop innovative therapies, personalized treatment plans tailored to each patient's tumour biology and health status will continue to play a critical role in optimizing treatment outcomes and quality of life.

5. Chemotherapy

Chemotherapy involves the use of drugs to kill cancer cells or inhibit their growth throughout the body. While less commonly used as a primary treatment for liver cancer, it may be considered in certain cases, particularly for advanced stages or when other treatments have not been effective in controlling the disease.

Mechanism:

• Administration: Chemotherapy drugs can be administered orally or intravenously (IV), allowing them to travel through the bloodstream to reach cancer cells throughout the body, including those in the liver.
• Cellular Targets: These drugs work by disrupting the cell cycle of rapidly dividing cancer cells, leading to cell death.
• Combination Therapies: Often used in combination with other treatments such as surgery, radiation therapy, or targeted therapy to improve treatment outcomes.

Clinical Application:

• Indications: Chemotherapy may be considered for patients with advanced liver cancer that has spread beyond the liver (metastatic disease) or when surgery or other treatments are not feasible.
• Types of Drugs: Common chemotherapy agents used for liver cancer include doxorubicin, cisplatin, and fluorouracil (5-FU). Newer combinations and formulations are continuously being researched to improve efficacy and reduce side effects.
• Side Effects: Potential side effects include nausea, vomiting, hair loss, fatigue, and increased susceptibility to infections. Supportive care and medications can help manage these side effects.

Monitoring and Follow-up:

• Response Assessment: Regular imaging studies (CT scans, MRI) and blood tests are used to monitor tumour response to chemotherapy and adjust treatment as needed.
• Quality of Life: Maintaining quality of life is a key consideration in the management of chemotherapy-related side effects, with supportive care tailored to individual patient needs.

6. Immunotherapy

 Immunotherapy represents a novel approach to cancer treatment that harnesses the power of the immune system to recognize and destroy cancer cells. It has shown promising results in the treatment of various cancers, including liver cancer, particularly in cases where traditional treatments have been less effective.

Mechanism:

• Enhancing Immune Response: Immunotherapy drugs, such as checkpoint inhibitors or monoclonal antibodies, work by either activating the immune system's ability to recognize cancer cells or by blocking mechanisms that allow cancer cells to evade immune detection and attack.
• Specific Targets: These therapies target specific molecules or proteins in cancer cells, enabling immune cells to identify and destroy them more effectively.
• Clinical Application: Immunotherapy is increasingly being studied and used in clinical settings for patients with advanced liver cancer, either as a standalone treatment or in combination with other therapies.

Types of Immunotherapy:

• Checkpoint Inhibitors: Drugs like pembrolizumab and nivolumab target checkpoint proteins (PD-1/PD-L1) that prevent immune cells from attacking cancer cells, thereby enhancing the immune response against liver cancer.
• Monoclonal Antibodies: Designed to target specific proteins on cancer cells or within the tumour microenvironment, these antibodies can help stimulate an immune response against liver cancer cells.

• Patient Selection: Immunotherapy is typically considered for patients with advanced liver cancer or those who have not responded to other treatments. Biomarker testing may be used to identify patients who are likely to benefit from specific immunotherapy drugs.
• Side Effects: While generally well-tolerated, immunotherapy can cause immune-related side effects (e.g., fatigue, rash, diarrhoea) that require close monitoring and management by healthcare providers.
• Research and Development: Ongoing clinical trials are exploring new immunotherapy approaches and combinations to further improve outcomes for patients with liver cancer.

7. Clinical Trials

 Clinical trials are research studies that evaluate the safety and efficacy of new treatments, therapies, or interventions for liver cancer. Participating in clinical trials provides patients with access to innovative treatments that are not yet widely available and contributes to advancing scientific knowledge in cancer treatment.

Benefits of Clinical Trials:

• Access to New Therapies: Participants may receive new treatments or therapies that have shown promise in preclinical studies or early-stage trials.
• Close Monitoring: Patients in clinical trials receive careful monitoring of their health and treatment responses, often with frequent visits and tests.
• Contribution to Research: By participating in clinical trials, patients contribute to the development of new treatments and help improve future standards of care for liver cancer.

Considerations:

• Informed Consent: Before enrolling in a clinical trial, patients receive detailed information about the study's purpose, potential risks and benefits, and their rights as participants.
• Patient Eligibility: Each clinical trial has specific eligibility criteria based on factors such as cancer stage, previous treatments, and overall health status.
• Types of Trials: Trials may involve new drugs, therapies, surgical techniques, or combinations of treatments aimed at improving outcomes for patients with liver cancer.

Chemotherapy, immunotherapy, and participation in clinical trials represent evolving treatment options for liver cancer, offering hope for improved outcomes and quality of life for patients. Personalized treatment approaches, guided by multidisciplinary teams and informed by ongoing research, are crucial in tailoring therapies to individual patient needs and maximizing treatment effectiveness.

How can HealthTrip assist with your treatment?

If you're seeking treatment for Liver Cancer, let HealthTrip be your compass. We support you throughout your medical journey with the following:

• Access to top doctors in 38+ countries and the largest health travel platform.
• Partnerships with 1500+ hospitals, including Fortis, Medanta, and more.
• Treatments in neuro, cardiac care, transplants, aesthetics, and wellness.
• Post-treatment care and assistance.
• Teleconsultations with leading doctors at $1/minute.
• Over 61K patients served.
• Access Top treatments and packages, such as Angiograms and many more.
• Gain insights from genuine patient experiences and testimonials.
• Stay updated with our medical blog.
• 24/7 unwavering support, from hospital formalities to travel arrangements or emergencies.

Hear from our satisfied patients